CIBC Innovation Banking announced today that it has provided a growth-focused credit facility to MedMe Health (“MedMe”). The company will use the financing to expand its product suite and scale its operations in North America.
Founded in 2019, MedMe has rapidly established itself as a leading platform for pharmacy care delivery in Canada, supporting over 4,500 pharmacies across North America. MedMe enables pharmacies to operate as true clinical hubs, delivering vaccinations, chronic disease management, and preventative care at scale.
“With growing traction in the US and the launch of AI-powered tools such as Clinical Assistant and Patient Concierge, MedMe is setting a new standard for how community providers engage, document, and care for patients,” said Purya Sarmadi, CEO and Co-Founder of MedMe. “We are excited to work with CIBC Innovation Banking to fuel our next stage of growth. This financing will accelerate our US expansion, extend our medical billing capabilities for pharmacist-led care, advance our AI roadmap, and scale our presence across specialty pharmacy and adjacent healthcare providers.”
Niramay, Executive Director at CIBC Innovation Banking, added “MedMe is helping to transform pharmacy care delivery with its innovative, customizable software platform. We are proud to support its next phase of growth as it expand into new markets and continues to drive digital transformation in the healthcare sector.”
MedMe is backed by leading investors including Microsoft’s M12, Graphite Ventures, MaRS IAF, and YCombinator.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
